Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
SPX Technologies Q1 2026 Earnings Call - Raised Full-Year Guidance on Data Center Surge and Margin Expansion
SPX Technologies delivered a strong Q1 2026, with revenue up 17.4% year-over-year and adjusted EPS rising 22% to $1.69. The company raised its full-year adjusted EPS guidance to a midpoint of $7.95, d...
- Revenue grew 17.4% year-over-year, driven by acquisitions and organic strength in HVAC and Detection & Measurement.
- Adjusted EPS rose 22% to $1.69, beating expectations and supporting a full-year guidance raise.
- Full-year adjusted EPS guidance increased by $0.15 to a midpoint of $7.95, reflecting strong Q1 performance and data center volume.
- +7 more takeaways
Sun Communities Q1 2026 Earnings Call - Core FFO Beats High-End Expectations, Guidance Raised Amid Manufacturing Housing Momentum
Sun Communities delivered a robust start to 2026, reporting Core FFO per share of $1.40, which beat the high end of the guidance range. The outperformance was driven by strong same-property NOI growth...
- Core FFO per share of $1.40 beat the high end of guidance, driven by strong manufactured housing fundamentals and better-than-expected RV transient performance.
- Full-year 2026 Core FFO per share guidance raised to $6.87-$7.07, a $0.04 increase at the midpoint, reflecting a strong start to the year and continued outperformance in core MH.
- North American same-property NOI increased 6.3%, with manufactured housing NOI up 6.3% and RV NOI up 6.3%, supported by site rent growth and disciplined expense management.
- +7 more takeaways
Cable One Q1 2026 Earnings Call - New CEO Focuses on Retention and Debt Reduction Amid Competitive Pressure
Cable One’s first quarter of 2026 results reflect a transitional phase under new CEO Jim Holanda, who is emphasizing operational consistency and customer retention amid intense competitive pressure. T...
- New CEO Jim Holanda, 70 days into his role, identifies operational inconsistency as the primary challenge, emphasizing that changes are early and not yet fully reflected in results.
- Residential broadband lost 12,600 net customers sequentially, with elevated churn concentrated in hyper-competitive markets, though new connects improved year-over-year.
- Revenue fell to $353 million from $380.6 million year-over-year, driven by a $10 million drop in residential video and a $11.6 million decline in residential data.
- +7 more takeaways
NMI Holdings First Quarter 2026 Earnings Call - Record Revenue and Steady Credit Normalization Drive Shareholder Returns
NMI Holdings delivered a record first quarter in 2026, generating $183.5 million in total revenue and $1.28 in adjusted diluted EPS. The company's insured portfolio reached a new high of $222.3 billio...
- Total revenue hit a record $183.5 million, up 2% sequentially and 6% year-over-year, driven by strong net premiums earned of $154.8 million.
- Adjusted net income reached $99.4 million, or $1.28 per diluted share, reflecting a 15.2% adjusted return on equity.
- New business volume surged 33% year-over-year to $12.3 billion, while primary insurance in force grew to a record $222.3 billion.
- +7 more takeaways
OrthoPediatrics Corp Q1 2026 Earnings Call - Raised Revenue Guidance Amidst Strong Product Launch Momentum
OrthoPediatrics delivered a solid Q1 2026, posting 13% year-over-year revenue growth to $59.4 million. The company raised its full-year revenue guidance to $263–$267 million, citing strong momentum fr...
- Revenue grew 13% year-over-year to $59.4 million, driven by strength across trauma, deformity, scoliosis, and specialty bracing segments.
- Full-year 2026 revenue guidance was raised to $263–$267 million, representing 11–13% growth, while adjusted EBITDA and free cash flow breakeven targets were reaffirmed.
- International revenue surged 22% year-over-year, outpacing domestic growth, with EMEA benefiting from EU MDR approvals and Brazil showing signs of stabilization after distributor acquisition.
- +7 more takeaways
Merit Medical Systems Q1 2026 Earnings Call - Margin Expansion and Strategic Oncology Acquisition Drive Results
Merit Medical Systems delivered a strong start to fiscal 2026 with Q1 revenue of $381.9 million, up 7% year-over-year on a GAAP basis and 5% on a constant currency basis, beating the high end of expec...
- Revenue of $381.9 million grew 7% year-over-year on a GAAP basis and 5% on a constant currency basis, exceeding the high end of Q4 2025 guidance.
- Non-GAAP operating margin expanded 47 basis points to 19.7%, marking the highest first-quarter operating margin in company history.
- Non-GAAP EPS increased 9% to $0.94, beating the high end of the guidance range by $0.07.
- +11 more takeaways
Dexcom Q1 2026 Earnings Call - Revenue Growth Accelerates on Type 2 Non-Insulin Coverage Wins and G7 15-Day Launch
Dexcom delivered a strong first quarter, with revenue growing 15% to $1.19 billion and organic growth of 12%. The company benefited from broader reimbursement access, particularly in the type 2 non-in...
- Dexcom reported Q1 2026 revenue of $1.19 billion, up 15% year-over-year, with organic growth of 12% after adjusting for foreign exchange and acquisitions/divestitures.
- U.S. revenue grew 11% to $832 million, driven by strong momentum in the type 2 non-insulin population and the launch of the G7 15-Day system.
- International revenue surged 26% to $360 million, with organic growth of 17%, fueled by recent reimbursement wins in markets like France and Canada.
- +7 more takeaways
Amgen Q1 2026 Earnings Call - MariTide Pivot to Less-Frequent Dosing Signals Bold Obesity Strategy
Amgen delivered a strong first quarter in 2026, with sales up 4% and six key growth drivers accounting for 70% of revenue. The company raised its full-year guidance, citing momentum across its diversi...
- Amgen reported 4% year-over-year product sales growth in Q1 2026, with six key growth drivers generating 70% of sales and growing 24% year-over-year.
- Management raised full-year 2026 guidance, projecting revenues of $37.1 billion to $38.5 billion and non-GAAP EPS of $21.70 to $23.10.
- MariTide, Amgen’s obesity and diabetes candidate, will undergo new Phase III studies evaluating switching from weekly GLP-1s to every 8-week or quarterly dosing.
- +12 more takeaways
Allegiant Travel Company Q1 2026 Earnings Call - Margin Expansion Defies Fuel Shock, Sun Country Close Imminent
Allegiant delivered a historic first quarter, posting a 14.9% adjusted operating margin and record revenue growth despite a 5.9% reduction in capacity. The airline’s disciplined focus on peak-day flyi...
- Adjusted operating margin expanded to 14.9%, marking the highest first-quarter margin in company history and outperforming guidance by nearly 6 percentage points year-over-year.
- Total revenue reached $732.4 million, a 9.6% year-over-year increase, driven by a 16.4% surge in TRASM despite a 5.9% reduction in available seat miles.
- Operational reliability remained elite with a 99.9% controllable completion factor, even amid winter weather disruptions and a higher mix of peak-day flying.
- +7 more takeaways
Stryker Q1 2026 Earnings Call - Cyber Incident Distorts Results But Full-Year Guidance Stands Firm
Stryker’s Q1 2026 results were heavily distorted by a late-quarter cyber incident that disrupted global manufacturing and delayed revenue recognition. Despite the operational shock, underlying demand ...
- Q1 2026 organic sales growth was 2.4% globally, with 1.9% in the U.S. and 3.9% internationally, significantly impacted by a late-quarter cyber incident.
- The cyber incident caused global operational disruptions, delaying revenue recognition and shipments, but manufacturing was fully operational by early April.
- Stryker reaffirmed its full-year 2026 guidance: 8%-9.5% organic sales growth and $14.90-$15.10 adjusted EPS, expecting most lost sales to be recovered throughout the year.
- +12 more takeaways